Skip to content

Clinical trials

Epilepsy trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Country / region: South Korea Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20053
20065
20075
20084
20103
20117
20124
20134
20144
20154
20165
20181
20192
20211
20223
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50
Unknown status6
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.8
Eisai Korea Inc.7
GlaxoSmithKline7
Seoul National University Hospital6
Eisai Inc.5
UCB BIOSCIENCES, Inc.5
Yonsei University4
UCB Pharma3
UCB BIOSCIENCES GmbH2
Asan Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy58
Seizures13
Epilepsies, Partial9
Dystonia1
Epilepsy, Complex Partial1
Epilepsy, Tonic-Clonic1
Essential Tremor1
Parkinson Disease1
Small Cell Lung Carcinoma1

Trials

Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.